ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $755K of Zentalis Pharmaceuticals, Inc.
Sold$754,861
$75.49Price
10,000Shares
−2%Stake
What ZNTL did after the filing
- The stock from Wed, Jan 5 close, $72.81
- −31.9%
- S&P 500, same days
- −6.7%
Measured over 30 trading days, to the Feb 17 close.
Traded Wed, Jan 5. Filed Wed, Jan 5, 12:49 PM ET, during the session. Returns use the Jan 5 close and the Feb 17 close. Not investment advice.